{"product_id":"9781441976208","title":"Ophthalmologic Drug Guide","description":"\u003ch1\u003eOphthalmologic Drug Guide\u003c\/h1\u003e \u003ch2\u003eRhee, Douglas J.; Colby, Kathryn A.; Sobrin, Lucia; Rapuano, Christopher J.\u003c\/h2\u003e \u003cp\u003eDrug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink\/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration  (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2010-12-03\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9781441976208\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-1-4419-7621-5\u003c\/p\u003e \u003cp\u003eDimensions: 203cm x127cm\u003c\/p\u003e \u003cp\u003ePages: 138\u003c\/p\u003e ","brand":"Springer New York","offers":[{"title":"Default Title","offer_id":47671495786636,"sku":"9781441976208","price":49.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781441976208.jpg?v=1776515995","url":"https:\/\/lateknightbooks.com\/products\/9781441976208","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}